1 09, 2021 Carlotta Antoniotti et al., Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study adlitterio663392022-10-14T12:18:31+02:00 Mehr erfahren
24 08, 2021 Umberto Malapelle et al., Reference standards for gene fusion molecular assays on cytological samples: an international validation study. adlitterio663392022-10-14T12:09:36+02:00 Mehr erfahren
23 08, 2021 Martina Lorenzi et al., First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study. adlitterio663392021-08-23T12:10:15+02:00 Mehr erfahren
19 08, 2021 Sabrina Rossi et al., Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC adlitterio663392022-10-21T09:20:25+02:00 Mehr erfahren
5 08, 2021 Antonio Marchetti et al., Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network adlitterio663392022-10-13T16:30:06+02:00 Mehr erfahren
22 07, 2021 Alessandro Pancrazzi et al., Experience of Uncommon EGFR Mutation in Lung Scheme Quality Program: Discussing Risks and Opportunities for the Improvement of Laboratory Response adlitterio663392022-10-14T12:20:42+02:00 Mehr erfahren
22 07, 2021 Pamela Trillo Aliaga et al., Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis. adlitterio663392022-10-21T09:25:42+02:00 Mehr erfahren
18 07, 2021 Alessandro Parisi et al., Clinicians‘ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, „Real-Life“, Case-Control Study adlitterio663392022-10-21T09:31:53+02:00 Mehr erfahren
13 07, 2021 Valentina Angerilli et al., Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas adlitterio663392022-10-21T09:34:56+02:00 Mehr erfahren
1 07, 2021 Cristina Morelli et al., Perfect concordance between blood-based and normal tissue-based dihydropyrimidine dehydrogenase polymorphisms suggests that pharmacogenetic screening could be contextual to tumour molecular profiling adlitterio663392022-10-14T12:26:32+02:00 Mehr erfahren
